Skip to search formSkip to main contentSkip to account menu

gemcitabine/vinorelbine

Known as: vinorelbine gemcitabine, Vinorelbine-Gemcitabine Regimen, gemcitabine vinorelbine 
A regimen consisting of vinorelbine and gemcitabine, used as a salvage regimen for relapsed, childhood Hodgkin's lymphoma following an autologous… 
National Institutes of Health

Related topics

Related topics

4 relations
Gemcitabine hydrochlorideVinorelbine tartratechildhood Hodgkin's lymphomavinorelbine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma.
2008
2008
Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: outcome data on a randomized phase II study
SummaryStudies with the gemcitabine/vinorelbine (GV) or the gemcitabine/docetaxel (GD) combinations have shown similar efficacy… 
Highly Cited
2006
Highly Cited
2006
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.
2006
2006
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site
To date, the standard treatment for patients who have carcinoma of unknown primary site has not been established. 
2005
2005
Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma
Anaplastic thyroid carcinoma (ATC) has a rapidly fatal course in the mostly elderly patients with a median survival after… 
2005
2005
Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.
BACKGROUND The purpose of this study was to compare quality of life and overall toxicity in patients with advanced non-small-cell… 
2000
2000
Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): an AASLC phase II trial. Austrian Association for the Study of Lung Cancer.
PURPOSE The purpose of the present phase 11 trial was to determine the efficacy and toxicity of vinorelbine-gemcitabine in… 
2000
2000
Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic…
BACKGROUND Gemcitabine and vinorelbine have shown activity in breast cancer. A phase II trial was initiated in order to evaluate… 
2000
2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.
PURPOSE Gemcitabine and vinorelbine are active drugs with broad spectrum of activity and manageable toxicity in clinical trials… 
Review
1999
Review
1999
Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer.
Combinations of vinorelbine with other nonplatinum agents show promising results in phase I and phase II trials in non-small cell… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)